| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1474 | 2019 |
| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell 182 (6), 1419-1440. e23, 2020 | 1289 | 2020 |
| Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies A Trickey, MT May, JJ Vehreschild, N Obel, MJ Gill, HM Crane, ... The lancet HIV 4 (8), e349-e356, 2017 | 1124 | 2017 |
| Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ... The Lancet infectious diseases 16 (7), 828-837, 2016 | 678 | 2016 |
| The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 FA Klok, GJAM Boon, S Barco, M Endres, JJM Geelhoed, S Knauss, ... European Respiratory Journal 56 (1), 2020 | 654 | 2020 |
| Patients at high risk of invasive fungal infections: when and how to treat MJGT Rüping, JJ Vehreschild, OA Cornely Drugs 68, 1941-1962, 2008 | 353 | 2008 |
| Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ... Immunity 53 (6), 1296-1314. e9, 2020 | 303 | 2020 |
| Forty-one recent cases of invasive zygomycosis from a global clinical registry MJGT Rueping, WJ Heinz, AJ Kindo, V Rickerts, C Lass-Floerl, C Beisel, ... Journal of Antimicrobial Chemotherapy 65 (2), 296-302, 2010 | 233 | 2010 |
| Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals Y Bar-On, H Gruell, T Schoofs, JA Pai, L Nogueira, AL Butler, K Millard, ... Nature medicine 24 (11), 1701-1707, 2018 | 232 | 2018 |
| Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis P Koehler, M Stecher, OA Cornely, D Koehler, MJGT Vehreschild, ... Clinical microbiology and infection 25 (10), 1200-1212, 2019 | 228 | 2019 |
| Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016 AJ Ullmann, M Schmidt-Hieber, H Bertz, WJ Heinz, M Kiehl, W Krüger, ... Annals of hematology 95, 1435-1455, 2016 | 213 | 2016 |
| Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for … OA Cornely, A Böhme, D Buchheidt, H Einsele, WJ Heinz, M Karthaus, ... haematologica 94 (1), 113, 2009 | 203 | 2009 |
| Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German … WJ Heinz, D Buchheidt, M Christopeit, M von Lilienfeld-Toal, OA Cornely, ... Annals of hematology 96, 1775-1792, 2017 | 185 | 2017 |
| Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ... Immunity 54 (11), 2650-2669. e14, 2021 | 179 | 2021 |
| Mucormycosis treated with posaconazole: review of 96 case reports JJ Vehreschild, A Birtel, MJGT Vehreschild, B Liss, F Farowski, ... Critical reviews in microbiology 39 (3), 310-324, 2013 | 174 | 2013 |
| COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry MM Rüthrich, C Giessen-Jung, S Borgmann, AY Classen, S Dolff, ... Annals of hematology 100, 383-393, 2021 | 172 | 2021 |
| Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in … BJ Liss, JJ Vehreschild, OA Cornely, M Hallek, G Fätkenheuer, ... Infection 40, 613-619, 2012 | 161 | 2012 |
| Cause-specific mortality in HIV-positive patients who survived ten years after starting antiretroviral therapy A Trickey, MT May, J Vehreschild, N Obel, MJ Gill, H Crane, C Boesecke, ... PloS one 11 (8), e0160460, 2016 | 137 | 2016 |
| Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML): a 6 year experience of the Cologne AML cohort JJ Vehreschild, M Rüping, H Wisplinghoff, F Farowski, A Steinbach, ... Journal of antimicrobial chemotherapy 65 (7), 1466-1471, 2010 | 134 | 2010 |
| Severe pneumonia and human bocavirus in adult B Kupfer, J Vehreschild, O Cornely, R Kaiser, G Plum, S Viazov, ... Emerging infectious diseases 12 (10), 1614, 2006 | 134 | 2006 |
